Belmont Global Advisors’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$8.42M Buy
303,255
+20,180
+7% +$534K 7.97% 5
2016
Q2
$6.9M Sell
283,075
-100,698
-26% -$2.86M 6.63% 5
2016
Q1
$12.9M Buy
383,773
+206,946
+117% +$6.52M 13.11% 1
2015
Q4
$5.28M Buy
176,827
+3,027
+2% +$102K 6.85% 3
2015
Q3
$5.48M Buy
173,800
+1,311
+0.8% +$64K 9.3% 2
2015
Q2
$8.34M Sell
172,489
-14,700
-8% -$620K 9.25% 2
2015
Q1
$8.12M Sell
187,189
-13,637
-7% -$490K 8.25% 2
2014
Q4
$5.28M Buy
200,826
+13,794
+7% +$302K 5.22% 2
2014
Q3
$3.32M Sell
187,032
-3,662
-2% -$74.8K 2.6% 7
2014
Q2
$4.58M Buy
190,694
+142,286
+294% +$2.88M 3.3% 5
2014
Q1
$1.22M Sell
48,408
-3,139
-6% -$86.9K 1.02% 26
2013
Q4
$1.17M Buy
+51,547
New +$1.04M 0.95% 27

Other funds holding PGEN

Belmont Global Advisors's PGEN Position: Q3 2016 in Review

Belmont Global Advisors increased its Precigen (PGEN) stake by 7.1% in Q3 2016, buying an estimated $534K and bringing the position to 303,255 shares worth $8.42M. The position accounts for 7.97% of the portfolio, ranked #5.

Belmont Global Advisors first reported a position in PGEN in Q4 2013 and has held it in 12 quarters since. The position peaked at $12.9M in Q1 2016. 168 funds tracked by Wall St. Rank hold PGEN as of Q3 2016.

  • Belmont Global Advisors held 303,255 shares of Precigen worth $8.42M as of Q3 2016.
  • Belmont Global Advisors bought 20,180 Precigen shares in Q3 2016, an estimated $534K.
  • Precigen made up 7.97% of Belmont Global Advisors's portfolio in Q3 2016, its #5 holding.
  • Belmont Global Advisors first reported a position in Precigen in Q4 2013 and has held it in 12 quarters since.
  • Belmont Global Advisors's Precigen position peaked at $12.9M in Q1 2016.
  • 168 funds tracked by Wall St. Rank held Precigen as of Q3 2016.

Based on Belmont Global Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.